STOCK TITAN

Cambium Networks Pursues Appeal of Nasdaq Delisting

(Neutral)
Tags

Cambium Networks (NASDAQ:CMBM) filed its Form 10-K for the year ended December 31, 2025 and quarterly reports for March, June and September 2025, bringing the company current with SEC periodic filings.

The company is appealing Nasdaq's delisting decision with an expected Nasdaq decision in Q2 2026 and says it may move trading to another OTC market if the appeal fails. Management says restatements for prior years are complete and anticipates filing the Q1 2026 report during May 2026.

Loading...
Loading translation...

Positive

  • Brought periodic SEC filings current by filing 2025 Form 10-K and three 2025 quarterly reports
  • Restatements for prior years completed, enabling return to normal filing cadence
  • Company expects Nasdaq appeal decision in Q2 2026, providing a clear near-term regulatory timeline

Negative

  • Nasdaq issued a delisting decision that the company is appealing
  • If appeal fails, ordinary shares could move from OTC Expert Market to another OTC tier, potentially reducing liquidity

Market Context

This announcement details that Cambium is current on its SEC periodic filings for 2024 and 2025, fol...
Analysis

This announcement details that Cambium is current on its SEC periodic filings for 2024 and 2025, following extensive restatements, and is appealing Nasdaq’s prior delisting decision while planning timely 2026 reports. Recent history shows large moves tied to listing status and filing compliance, including a sharp reaction to the March 2026 delisting decision. Investors may watch the Nasdaq appeal outcome, future filing timeliness, and any further regulatory correspondence as key markers of risk.

Key Figures

2025 Form 10-K year-end: December 31, 2025 2024 Form 10-K year-end: December 31, 2024 Quarterly periods filed: March 31, June 30, September 30, 2025 +5 more
8 metrics
2025 Form 10-K year-end December 31, 2025 Year-end for newly filed annual report
2024 Form 10-K year-end December 31, 2024 Year-end for comprehensive annual report filed three weeks earlier
Quarterly periods filed March 31, June 30, September 30, 2025 Quarters for which 2025 Forms 10-Q were filed
Restated annual period December 31, 2023 Year-end for restated annual report
Appeal decision timing Q2 2026 Expected timing for Nasdaq appeal decision
Next 10-Q timing May 2026 Anticipated filing month for Q1 2026 Form 10-Q
Current share price $0.401 Price before this news, down 77.34% over 24h
52-week high $6.80 Reference for long-term price compression

Historical Context

5 past events · Latest: Mar 26 (Negative)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Mar 26 Nasdaq delisting decision Negative -77.3% Nasdaq Hearings Panel decision to delist shares and move trading to OTC.
Jan 14 Product capability update Positive +3.3% Announcement of NSE platform enhancements for LEO satellite and LTE/5G links.
Dec 18 Partial compliance, CFO change Positive -1.9% Nasdaq partial compliance on bid-price and appointment of Interim CFO.
Dec 05 Continued listing granted Positive +9.8% Nasdaq panel grants continued listing subject to bid-price and filing conditions.
Dec 01 Additional deficiency letter Negative -13.1% Nasdaq letter citing delinquent Q3 2025 10-Q and prior late filings.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Nasdaq compliance and listing developments have repeatedly driven sharp moves, with generally aligned reactions except for one compliance-related headline that saw a modest decline.

Recent Company History

Over the past six months, Cambium’s news flow has centered on Nasdaq listing status and SEC filing compliance. A March 25, 2026 delisting decision coincided with a -77.34% move. Earlier, a December 3, 2025 panel decision granting continued listing and setting bid-price and filing milestones saw a 9.83% gain, while an additional staff determination letter on Nov 25, 2025 about delinquent filings matched a -13.11% reaction. Today’s update about being current on SEC filings and appealing Nasdaq’s delisting fits into this ongoing compliance narrative.

Key Terms

form 10-k, securities and exchange commission, nasdaq global market, otc expert market, +1 more
5 terms
form 10-k regulatory
"filed its annual report on Form 10-K for the year ended December 31, 2025"
A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.
securities and exchange commission regulatory
"current with its filings of its periodic reports with the Securities and Exchange Commission"
A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.
nasdaq global market regulatory
"decision to delist the Company's ordinary shares from the Nasdaq Global Market"
The Nasdaq Global Market is a section of the stock exchange where larger, well-established companies are listed and publicly traded. It functions like a marketplace where investors can buy and sell shares of these companies, providing them with access to capital and opportunities for growth. Its role is important because it helps investors identify and invest in reputable companies with strong financial backgrounds.
otc expert market financial
"seek to move from the OTC Expert Market to one of the other OTC markets"
An OTC expert market is an over-the-counter trading venue where securities that don’t meet the rules of main exchanges are bought and sold, and access is typically limited to professional or sophisticated investors. It matters to investors because these markets often have less public information, lower trading volume and higher price swings — like a specialized flea market where only experienced buyers trade rarer, riskier items, so potential reward and risk are both amplified.
periodic reports regulatory
"current with its filings of its periodic reports with the Securities and Exchange Commission"
Regularly scheduled documents that a publicly traded company must provide to disclose its financial results, business operations, risks and significant events — like a report card showing revenue, profits, cash flow and key changes over a set period. Investors use these reports to judge a company's health and trends, compare performance over time, and make informed buy, hold or sell decisions; they act as a routine check-up for financial transparency.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Becomes Current in its SEC Filings

HOFFMAN ESTATES, Ill., May 4, 2026 /PRNewswire/ -- Cambium Networks Corporation ("Cambium Networks" or the "Company"), a leading global provider of networking solutions, announced today that the Company filed its annual report on Form 10-K for the year ended December 31, 2025 in addition to filing its quarterly reports for the quarters ended March 31, June 30 and September 30, 2025. This comes just three weeks after the Company released its comprehensive annual report on Form 10-K for the year ended December 31, 2024. The Company is now current with its filings of its periodic reports with the Securities and Exchange Commission ("SEC").

As previously disclosed, the Company is appealing The Nasdaq Stock Market's decision to delist the Company's ordinary shares from the Nasdaq Global Market and expects a decision from Nasdaq in the second quarter of 2026. If the appeal is not successful, the Company will seek to move from the OTC Expert Market to one of the other OTC markets, to enable easier trading in the Company's ordinary shares.

We have demonstrated our ability to quickly file our 2025 financial reports following the filing of our comprehensive annual report for the year ended December 31, 2024, including the restatement of our annual report for the year ended December 31, 2023, and the quarterly reports for 2023 and 2024. With the restatements behind us, we believe we are back on track with our usual cadence of filing our period reports with the SEC. While we are pleased to have these accounting issues behind us, we reiterate that the accounting issues leading to our restatements do not impact our operations or our ability to deliver the high-quality products expected of Cambium. The Company anticipates that it will be in a position to file its quarterly report for the quarter ending March 31, 2026, during May 2026 and is confident that we will be able to timely file all future reports.

About Cambium Networks
Cambium Networks enables service providers, enterprises, industrial organizations, and governments to deliver exceptional digital experiences, and device connectivity, with compelling economics. Our ONE Network platform simplifies management of Cambium Networks' wired and wireless broadband and network edge technologies. Our customers can focus more resources on managing their business rather than the network. We make connectivity that just works.

Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to statements relating to the trading of the Company's ordinary shares on the OTC market, the success of the Company' appeal of its Nasdaq delisting, as well as words such as "expects," "anticipates," "intends," "believes," "may," "should," "could," "would," and variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based upon the Company's current assumptions, beliefs, and expectations. Forward-looking statements are subject to the occurrence of many events outside of the Company's control. Actual results and the timing of events may differ materially from those contemplated by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things, the Company's trading on the OTC market, and its ability to return to The Nasdaq Stock Market and maintain compliance with Nasdaq continued listing standards. Forward-looking statements should be considered in light of these risks and uncertainties. Investors and others are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained herein speak only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Contacts:
Investor Relations
Cambium Networks
investors@Cambiumnetworks.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cambium-networks-pursues-appeal-of-nasdaq-delisting-302761908.html

SOURCE Cambium Networks

FAQ

Are Cambium Networks (CMBM) SEC filings current as of May 4, 2026?

Yes, Cambium Networks filed its 2025 Form 10-K and three 2025 quarterly reports, bringing filings current. According to the company, completing these filings followed prior restatements and returns the company to its usual SEC reporting cadence.

What is the status of Nasdaq's delisting decision for CMBM and when is a decision expected?

Cambium Networks is appealing Nasdaq's delisting decision and expects a Nasdaq ruling in Q2 2026. According to the company, the appeal outcome will determine whether shares remain listed or potential trading moves occur on OTC markets.

What will Cambium Networks do if the Nasdaq appeal is unsuccessful for CMBM?

If the appeal fails, the company plans to seek transfer from the OTC Expert Market to another OTC market to enable easier trading. According to the company, this move aims to preserve share tradability for investors.

Has Cambium Networks completed prior accounting restatements that affected CMBM filings?

Yes, the company says restatements for the 2023 annual report and quarterly reports for 2023–2024 are complete. According to the company, completing those restatements allowed it to file the 2025 reports and resume normal reporting cadence.